Literature DB >> 7294005

Secretory antibody response to respiratory syncytial virus infection.

T N Kaul, R C Welliver, D T Wong, R A Udwadia, K Riddlesberger, P L Ogra.   

Abstract

The secretory antibody response to primary and secondary infection with respiratory syncytial virus (RSV) in Igg, IgM and 11S IgA immunoglobulin classes was determined using an indirect immunofluorescence antibody technique. Nasopharyngeal secretions were collected after naturally acquired primary or secondary infection with RSV. Immunoglobulin A responses to RSV were significantly greater in infants older than 6 months of age at the time of infection than in younger infants. Reinfection with RSV resulted in enhanced antibody production in all three immunoglobulin classes, and virus-specific antibody persisted for longer periods after secondary infection. Repeated immunizations with live RSV vaccine may be necessary for the development of immunity to severe illness.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7294005     DOI: 10.1001/archpedi.1981.02130350017007

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  20 in total

Review 1.  Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections.

Authors:  D Nadal; P L Ogra
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Antibody response to respiratory syncytial virus infection in children <18 months old.

Authors:  Susanna Esposito; Elisa Scarselli; Mara Lelii; Alessia Scala; Alessandra Vitelli; Stefania Capone; Marco Fornili; Elia Biganzoli; Annalisa Orenti; Alfredo Nicosia; Riccardo Cortese; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 3.  Detection, pathogenesis, and therapy of respiratory syncytial virus infections.

Authors:  R C Welliver
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

4.  T cell redistribution kinetics after secondary infection of BALB/c mice with respiratory syncytial virus.

Authors:  J L Kimpen; P L Ogra
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

5.  Development of cell-mediated cytotoxic activity in the respiratory tract after experimental infection with respiratory syncytial virus.

Authors:  T Kumagai; D T Wong; P L Ogra
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

Review 6.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

7.  Class-specific antibodies to bovine respiratory syncytial virus in experimentally infected lambs.

Authors:  R Sharma; Z Woldehiwet
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

8.  Comparison of two new tests for rapid diagnosis of respiratory syncytial virus infections by enzyme-linked immunosorbent assay and immunofluorescence techniques.

Authors:  F Freymuth; M Quibriac; J Petitjean; M L Amiel; P Pothier; A Denis; J F Duhamel
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

9.  Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses.

Authors:  Richard Singleton; Nathalie Etchart; Sam Hou; Lisa Hyland
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Development of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus.

Authors:  T N Kaul; R C Welliver; P L Ogra
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.